On November 20^th to 21th, Li Haiyan, director of Drug Clinical Trial Institution, was invited to The 2rd International Conference on First and Early Clinical Studies as well as another six members in the institution. As special guest, Li Haiyan attended a seminar on CFDA`s update of policy and regulations and Chinese future of new drug development. Six papers from PUTH were elected in poster exhibition, one of which was awarded Excellent Poster Award. During the conference, institution members visited First Clinical Research Center of Queen Mary Hospital in Hong Kong, and they had a warm discussion on professional problems.

Translated by Zhang Dongrui

Proofed by Sun Xue, Fu Xiaoyi